Asahikawa Medical College Hospital

Asahikawa, Hokkaido 078-8510

1 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Crohn's Disease, Eczema, Hypertension, Pulmonary, Psoriasis

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed